These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 14605165

  • 1. In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.
    Fernández-Torres B, Inza I, Guarro J.
    J Clin Microbiol; 2003 Nov; 41(11):5209-11. PubMed ID: 14605165
    [Abstract] [Full Text] [Related]

  • 2. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes.
    Fernández-Torres B, Cabañes FJ, Carrillo-Muñoz AJ, Esteban A, Inza I, Abarca L, Guarro J.
    J Clin Microbiol; 2002 Nov; 40(11):3999-4003. PubMed ID: 12409365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
    Carrillo-Muñoz AJ, Guglietta A, Palacín C, Casals J, del Valle O, Guardià C, Rodríguez V, Quindós G.
    Chemotherapy; 2004 Dec; 50(6):308-13. PubMed ID: 15608448
    [Abstract] [Full Text] [Related]

  • 5. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK, Kohli Y.
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum.
    Fernández-Torres B, Vázquez-Veiga H, Llovo X, Pereiro M, Guarro J.
    Chemotherapy; 2000 Aug; 46(6):390-4. PubMed ID: 11053904
    [Abstract] [Full Text] [Related]

  • 15. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK, Sharma PC.
    Indian J Med Microbiol; 2015 Aug; 33(4):533-7. PubMed ID: 26470960
    [Abstract] [Full Text] [Related]

  • 16. Lyophilized microculture susceptibility test for ketoconazole, miconazole, clotrimazole, and griseofulvin against dermatophytes.
    Granade TC, Mothershead MA, Artis WM.
    J Clin Microbiol; 1983 Jul; 18(1):10-4. PubMed ID: 6309896
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay.
    Favre B, Hofbauer B, Hildering KS, Ryder NS.
    J Clin Microbiol; 2003 Oct; 41(10):4817-9. PubMed ID: 14532230
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New imidazole derivates: in-vitro activity on dermatophytes.
    Tullio V, Cuffini AM, Carlone NA, Spignoli G.
    J Chemother; 1991 Jan; 3 Suppl 1():43-6. PubMed ID: 12041784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.